301033
vs
S
Shanghai Composite
301033
Over the past 12 months, Medprin Regenerative Medical Technologies Co Ltd has significantly outperformed Shanghai Composite, delivering a return of +56% compared to the Shanghai Composite's +23% growth.
Stocks Performance
301033 vs Shanghai Composite
Performance Gap
301033 vs Shanghai Composite
Performance By Year
301033 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Medprin Regenerative Medical Technologies Co Ltd
Glance View
Medprin Regenerative Medical Technologies Co. Ltd. engages in the development of implanted medical devices. The company is headquartered in Guangzhou, Guangdong and currently employs 271 full-time employees. The company went IPO on 2021-07-26. The firm's implanted medical device products include artificial dura mater (spine) patch, cranio-maxillofacial repair products and absorbable hemostatic yarns. 3D printing equipment includes biological 3D printers, resin 3D printers and other related supporting components. Technical services include general technical services and scientific research services. The firm distributes its products both in the domestic market and to overseas markets.